- Home
- BRLT vs CDIO Comparison
BRLT vs CDIO Comparison
Compare BRLT & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRLT
- CDIO
- Stock Information
- Founded
- BRLT 2005
- CDIO 2017
- Country
- BRLT United States
- CDIO United States
- Employees
- BRLT N/A
- CDIO N/A
- Industry
- BRLT Consumer Specialties
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BRLT Consumer Discretionary
- CDIO Health Care
- Exchange
- BRLT Nasdaq
- CDIO Nasdaq
- Market Cap
- BRLT 22.6M
- CDIO 19.5M
- IPO Year
- BRLT 2021
- CDIO N/A
- Fundamental
- Price
- BRLT $1.50
- CDIO $0.46
- Analyst Decision
- BRLT Hold
- CDIO Buy
- Analyst Count
- BRLT 4
- CDIO 1
- Target Price
- BRLT $2.20
- CDIO $2.00
- AVG Volume (30 Days)
- BRLT 40.5K
- CDIO 763.1K
- Earning Date
- BRLT 05-06-2025
- CDIO 05-14-2025
- Dividend Yield
- BRLT N/A
- CDIO N/A
- EPS Growth
- BRLT N/A
- CDIO N/A
- EPS
- BRLT 0.03
- CDIO N/A
- Revenue
- BRLT $422,161,000.00
- CDIO $34,890.00
- Revenue This Year
- BRLT $3.81
- CDIO $1,434.82
- Revenue Next Year
- BRLT $4.48
- CDIO $4,661.91
- P/E Ratio
- BRLT $47.98
- CDIO N/A
- Revenue Growth
- BRLT N/A
- CDIO 104.45
- 52 Week Low
- BRLT $1.25
- CDIO $0.19
- 52 Week High
- BRLT $2.75
- CDIO $1.77
- Technical
- Relative Strength Index (RSI)
- BRLT 50.92
- CDIO 58.99
- Support Level
- BRLT $1.37
- CDIO $0.30
- Resistance Level
- BRLT $1.60
- CDIO $0.43
- Average True Range (ATR)
- BRLT 0.12
- CDIO 0.05
- MACD
- BRLT 0.00
- CDIO 0.01
- Stochastic Oscillator
- BRLT 65.03
- CDIO 93.41
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.